Orofacial cleft 11

disease
On this page

Also known as BMP4 orofacial cleftOFC11orofacial cleft caused by mutation in BMP4orofacial cleft type 11

Summary

Orofacial cleft 11 (MONDO:0010906) is a disease caused by BMP4 (GenCC Strong), with 2 cohort genes.

At a glance

  • Causal gene: BMP4 (GenCC Strong)
  • Cohort genes: 2
  • ClinVar variants: 204

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameorofacial cleft 11
Mondo IDMONDO:0010906
OMIM600625
DOIDDOID:0080404
UMLSC2677434
MedGen436944
GARD0018303
Is cancer (heuristic)no

Also known as: BMP4 orofacial cleft · OFC11 · orofacial cleft 11 · orofacial cleft caused by mutation in BMP4 · orofacial cleft type 11

Data availability: 204 ClinVar variants · 2 GenCC gene-disease records.

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary diseaseorofacial cleftcleft lip/palateorofacial cleft 11

Related subtypes (3): orofacial cleft 5, orofacial cleft 10, orofacial cleft 15

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

204 retrieved; paginated sample, class counts are floors:

120 uncertain significance, 39 likely benign, 26 conflicting classifications of pathogenicity, 8 benign/likely benign, 7 benign, 4 pathogenic

ClinVarVariant (HGVS)GeneClassificationReview
1071168NC_000014.8:g.(?_54416336)_54418690delBMP4Pathogeniccriteria provided, single submitter
1458344NM_001202.6(BMP4):c.205_214del (p.Arg69fs)BMP4Pathogeniccriteria provided, single submitter
29616NM_001202.6(BMP4):c.592C>T (p.Arg198Ter)BMP4Pathogeniccriteria provided, multiple submitters, no conflicts
1455396NC_000014.8:g.(?54416750)(55369403_?)delSAMD4APathogeniccriteria provided, single submitter
1195040NM_001202.6(BMP4):c.677G>A (p.Arg226Gln)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
1311100NM_001202.6(BMP4):c.351G>A (p.Val117=)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
1331305NM_001202.6(BMP4):c.766C>T (p.Arg256Ter)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
1381981NM_001202.6(BMP4):c.118G>A (p.Gly40Ser)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
1595389NM_001202.6(BMP4):c.485G>A (p.Arg162Gln)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
1691786NM_001202.6(BMP4):c.863G>A (p.Arg288Gln)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
17703NM_001202.6(BMP4):c.272C>G (p.Ser91Cys)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
2063217NM_001202.6(BMP4):c.838C>T (p.Arg280Trp)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
2205310NM_001202.6(BMP4):c.1099A>C (p.Ser367Arg)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
225304NM_001202.6(BMP4):c.751C>T (p.His251Tyr)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
2927135NM_001202.6(BMP4):c.461C>T (p.Ser154Phe)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
29618NM_001202.6(BMP4):c.362A>G (p.His121Arg)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
3026515NM_001202.6(BMP4):c.856C>T (p.Arg286Ter)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
313345NM_001202.6(BMP4):c.*149G>ABMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
313354NM_001202.6(BMP4):c.215A>G (p.Gln72Arg)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
388306NM_001202.6(BMP4):c.898C>T (p.Arg300Trp)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
424492NM_001202.6(BMP4):c.512G>A (p.Trp171Ter)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
468357NM_001202.6(BMP4):c.76T>C (p.Leu26=)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
497489NM_001202.6(BMP4):c.676C>T (p.Arg226Trp)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
725943NM_001202.6(BMP4):c.502G>C (p.Gly168Arg)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
767320NM_001202.6(BMP4):c.345C>T (p.Asn115=)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
881587NM_001202.6(BMP4):c.*31T>ABMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
881629NM_001202.6(BMP4):c.124G>C (p.Ala42Pro)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
882739NM_001202.6(BMP4):c.753T>C (p.His251=)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
882740NM_001202.6(BMP4):c.673A>G (p.Thr225Ala)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
883532NM_001202.6(BMP4):c.305C>T (p.Thr102Ile)BMP4Conflicting classifications of pathogenicitycriteria provided, conflicting classifications

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 10 · Orphanet: 4 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

GenCC gene–disease validity (cohort genes)

the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.

GeneClassificationInheritanceDiseaseRecords
BMP4StrongAutosomal dominantorofacial cleft 1110

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
BMP4Orphanet:139471Microphthalmia with brain and digit anomalies
BMP4Orphanet:199306Cleft lip/palate
BMP4Orphanet:828Stickler syndrome
BMP4Orphanet:93100Renal agenesis, unilateral

Cohort genes → proteins

2 cohort genes, 2 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence2

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
BMP4HGNC:1071ENSG00000125378P12644Bone morphogenetic protein 4gencc,clinvar
SAMD4AHGNC:23023ENSG00000020577Q9UPU9Protein Smaug homolog 1clinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
BMP4Bone morphogenetic protein 4Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including neurogenesis, vascular development, angiogenesis and osteogenesis.
SAMD4AProtein Smaug homolog 1Acts as a translational repressor of SRE-containing messengers.

Protein-family classification

Druggable: 0 · Difficult: 0 · Unknown: 2 · Druggable fraction: 0.0

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Other/Unknown21.8×0.312

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
BMP4Other/UnknownnoTGF-b_propeptide, TGF-b_C, TGF-beta-like
SAMD4AOther/UnknownnoSAM, SAM/pointed_sf, PHAT_dom_sf

Expression context

Cohort genes with no expression data: 0.

2 cohort genes are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)2
unknown0

Top tissues across cohort

TissueCohort genes
pigmented layer of retina1
rectum1
retina1
dorsal motor nucleus of vagus nerve1
heart right ventricle1
inferior olivary complex1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
BMP4189ubiquitousmarkerpigmented layer of retina, retina, rectum
SAMD4A288ubiquitousmarkerdorsal motor nucleus of vagus nerve, inferior olivary complex, heart right ventricle

Protein interactions among cohort

Intra-cohort edges: 0.

Hub genes (top 10 by interactor count)

SymbolInteractor count
BMP44,425
SAMD4A1,078

Structural data

PDB: 1 · AlphaFold-only: 1 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
SAMD4AQ9UPU91

AlphaFold-only cohort genes (top 30 by pLDDT)

SymbolUniProtpLDDT
BMP4P1264479.12

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 19. Enrichment computed across 2 evidence-associated genes (1 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
Formation of lateral plate mesoderm12284.0×0.004BMP4
Formation of intermediate mesoderm11427.5×0.004BMP4
Specification of primordial germ cells1878.5×0.004BMP4
Kidney development1815.7×0.004BMP4
Germ layer formation at gastrulation1671.8×0.004BMP4
Formation of the nephric duct1634.4×0.004BMP4
Specification of the neural plate border1634.4×0.004BMP4
Formation of the ureteric bud1496.5×0.005BMP4
Formation of paraxial mesoderm1407.9×0.005BMP4
Elastic fibre formation1335.9×0.006BMP4
Molecules associated with elastic fibres1308.6×0.006BMP4
Gastrulation1259.6×0.006BMP4
Reproduction1190.3×0.008BMP4
Post-translational protein phosphorylation1100.2×0.014BMP4
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)186.5×0.015BMP4
Extracellular matrix organization163.1×0.019BMP4
Post-translational protein modification119.2×0.058BMP4
Developmental Biology114.5×0.073BMP4
Metabolism of proteins112.4×0.081BMP4

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 2 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
intermediate mesodermal cell differentiation18426.0×0.002BMP4
positive regulation of cardiac muscle fiber development18426.0×0.002BMP4
bronchus development18426.0×0.002BMP4
bud dilation involved in lung branching18426.0×0.002BMP4
mammary gland formation18426.0×0.002BMP4
negative regulation of mesenchymal cell proliferation involved in ureter development18426.0×0.002BMP4
negative regulation of glomerulus development18426.0×0.002BMP4
regulation of mesodermal cell differentiation18426.0×0.002BMP4
negative regulation of metanephric S-shaped body morphogenesis18426.0×0.002BMP4
negative regulation of metanephric comma-shaped body morphogenesis18426.0×0.002BMP4
tendon cell differentiation14213.0×0.002BMP4
positive regulation of branching involved in lung morphogenesis14213.0×0.002BMP4
negative regulation of glomerular mesangial cell proliferation14213.0×0.002BMP4
negative regulation of branching involved in ureteric bud morphogenesis14213.0×0.002BMP4
positive regulation of primary miRNA processing14213.0×0.002BMP4
mesodermal cell fate determination12808.7×0.002BMP4
specification of animal organ position12808.7×0.002BMP4
regulation of cell fate commitment12808.7×0.002BMP4
deltoid tuberosity development12808.7×0.002BMP4
trachea development12808.7×0.002BMP4
glomerular capillary formation12808.7×0.002BMP4
nephric duct formation12808.7×0.002BMP4
positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis12808.7×0.002BMP4
lens induction in camera-type eye12106.5×0.002BMP4
prostatic bud formation12106.5×0.002BMP4
epithelial-mesenchymal cell signaling12106.5×0.002BMP4
negative regulation of prostatic bud formation12106.5×0.002BMP4
regulation of protein import into nucleus11685.2×0.002BMP4
negative regulation of striated muscle tissue development11685.2×0.002BMP4
regulation of smooth muscle cell differentiation11685.2×0.002BMP4

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 2

Druggability breadth: 1 of 2 evidence-associated genes (50%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
BMP400
SAMD4A00

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 0.

Cohort genes with ChEMBL bioactivity (full, sorted by assay count)

SymbolAssaysType breakdown
BMP42Binding:2

Pharmacogenomics

Cohort genes with a PharmGKB record: 2; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug0
DDruggable family + AlphaFold only, no drug0
EDifficult family or no structure, no drug2BMP4, SAMD4A

Undrugged target profiles

2 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
BMP42
SAMD4A0

Clinical trials & evidence

Clinical trials

Clinical trials: 0.